1. Home
  2. COSM vs TOVX Comparison

COSM vs TOVX Comparison

Compare COSM & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosmos Health Inc.

COSM

Cosmos Health Inc.

HOLD

Current Price

$0.25

Market Cap

15.8M

Sector

Health Care

ML Signal

HOLD

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.25

Market Cap

14.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COSM
TOVX
Founded
2009
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8M
14.7M
IPO Year
2009
2012

Fundamental Metrics

Financial Performance
Metric
COSM
TOVX
Price
$0.25
$0.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
1.2M
1.4M
Earning Date
04-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
46.15
89.07
EPS
N/A
N/A
Revenue
$65,271,815.00
N/A
Revenue This Year
$54.08
N/A
Revenue Next Year
$32.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.93
N/A
52 Week Low
$0.25
$0.16
52 Week High
$1.32
$0.86

Technical Indicators

Market Signals
Indicator
COSM
TOVX
Relative Strength Index (RSI) 38.07 36.63
Support Level $0.25 $0.18
Resistance Level $0.41 $0.27
Average True Range (ATR) 0.02 0.03
MACD 0.00 -0.01
Stochastic Oscillator 4.25 4.77

Price Performance

Historical Comparison
COSM
TOVX

About COSM Cosmos Health Inc.

Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

Share on Social Networks: